Trial Profile
A retrospective study to evaluate the safety and efficacy of tocilizumab in patients with takayasu arteritis refractory to standard treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jul 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Takayasu syndrome
- Focus Therapeutic Use
- 30 Jul 2015 New trial record
- 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.